Quantifying the CDK inhibitor VMY-1-103’s activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI-Reference-Cited by-同舟云学术

Quantifying the CDK inhibitor VMY-1-103’s activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI

Published:2012-09-14 Issue:20 Volume:11 Page:3801-3809
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Sirajuddin Paul¹,Das Sudeep²,Ringer Lymor¹,Rodriguez Olga C.¹,Sivakumar Angiela¹,Lee Yi-Chien¹,Uren Aykut¹,Fricke Stanley T.³,Rood Brian³,Ozcan Alpay⁴,Wang Sean S.¹,Karam Sana⁵,Yenugonda Venkata⁶,Salinas Patricia¹,Petricoin III Emanuel⁷,Pishvaian Michael¹,Lisanti Michael P.⁸,Wang Yue⁴⁹,Schlegel Richard¹¹⁰,Moasser Bahram²,Albanese Chris¹¹⁰

Affiliation:

1. Lombardi Comprehensive Cancer Center and Department of Oncology; Georgetown University Medical Center; Washington, DC USA

2. Department of Chemistry; Georgetown University; Washington, DC USA

3. Children’s National Medical Center; Washington, DC USA

4. Department of Physics; Virginia Tech; Arlington, VA USA

5. Department of Radiation Biology; Georgetown University Medical Center; Washington, DC USA

6. Drug Discovery Program; Georgetown University Medical Center; Washington, DC USA

7. Center for Applied Proteomics and Molecular Medicine; School of Systems Biology; George Mason University; Manassas, VA USA

8. Department Stem Cell Biology; Kimmel Cancer Center; Thomas Jefferson University; Philadelphia, PA USA

9. Bradley Department of Electrical and Computer Engineering; Virginia Tech; Arlington, VA USA

10. Department of Pathology; Georgetown University Medical Center; Washington, DC USA

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.4161/cc.21988

Reference34 articles.

1. Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase;Paternot;Cell Cycle,2010

2. Will PI3K pathway inhibitors be effective as single agents in patients with cancer?;Garrett;Oncotarget,2011

3. Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition;Beloueche-Babari;Oncotarget,2010

4. PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation;van Vuurden;Oncotarget,2011

5. A miniaturized arrayed assay format for detecting small molecule-protein interactions in cells;You;Chem Biol,1997

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of new targets for glioblastoma therapy based on a DNA expression microarray;Computers in Biology and Medicine;2024-09

2. Cerebral Creatine Deficiency Affects the Timing of Oligodendrocyte Myelination;The Journal of Neuroscience;2023-02-02

3. Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma;Nature Communications;2022-04-28

4. Skilled reach training enhances robotic gait training to restore overground locomotion following spinal cord injury in rats;Behavioural Brain Research;2021-09

5. Optical and magnetic resonance imaging approaches for investigating the tumour microenvironment: state-of-the-art review and future trends;Nanotechnology;2020-11-18